{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:56:45Z","timestamp":1793987805991,"version":"4.8.0"},"reference-count":137,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA1303804"],"award-info":[{"award-number":["2022YFA1303804"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004147","name":"Tsinghua University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004147","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes & Diseases"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.gendis.2025.101653","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T04:05:50Z","timestamp":1745467550000},"page":"101653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Role of chitinase-3-like protein 1 in liver diseases: A comprehensive review"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1759-9693","authenticated-orcid":false,"given":"Chao","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7099-1155","authenticated-orcid":false,"given":"Shizhou","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baochen","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gendis.2025.101653_bib1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1146\/annurev-physiol-012110-142250","article-title":"Role of chitin and chitinase\/chitinase-like proteins in inflammation, tissue remodeling, and injury","volume":"73","author":"Lee","year":"2011","journal-title":"Annu Rev Physiol"},{"issue":"pt 3","key":"10.1016\/j.gendis.2025.101653_bib2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1042\/bj20040099","article-title":"The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha","volume":"380","author":"Ling","year":"2004","journal-title":"Biochem J"},{"issue":"Pt 1","key":"10.1016\/j.gendis.2025.101653_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1042\/bj20020075","article-title":"The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways","volume":"365","author":"Recklies","year":"2002","journal-title":"Biochem J"},{"issue":"6","key":"10.1016\/j.gendis.2025.101653_bib4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1089\/omi.2015.0037","article-title":"CHI3L1 is a liver-enriched, noninvasive biomarker that can be used to stage and diagnose substantial hepatic fibrosis","volume":"19","author":"Huang","year":"2015","journal-title":"OMICS"},{"key":"10.1016\/j.gendis.2025.101653_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107394","article-title":"Roles of chitinase 3-like 1 in the development of cancer, neurodegenerative diseases, and inflammatory diseases","volume":"203","author":"Yeo","year":"2019","journal-title":"Pharmacol Ther"},{"issue":"50","key":"10.1016\/j.gendis.2025.101653_bib6","doi-asserted-by":"crossref","first-page":"41213","DOI":"10.1074\/jbc.M510146200","article-title":"Inflammatory cytokines induce production of CHI3L1 by articular chondrocytes","volume":"280","author":"Recklies","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.gendis.2025.101653_bib7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2147\/CMAR.S229083","article-title":"LINC00963 promotes ovarian cancer proliferation, migration and EMT via the miR-378g\/CHI3L1 axis","volume":"12","author":"Liu","year":"2020","journal-title":"Cancer Manag Res"},{"issue":"11","key":"10.1016\/j.gendis.2025.101653_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050826","article-title":"Hepatitis C virus mediated changes in miRNA-449a modulates inflammatory biomarker YKL40 through components of the NOTCH signaling pathway","volume":"7","author":"Sarma","year":"2012","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.gendis.2025.101653_bib9","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.7150\/thno.26467","article-title":"Suppression of metastasis through inhibition of chitinase 3-like 1 expression by miR-125a-3p-mediated up-regulation of USF1","volume":"8","author":"Kim","year":"2018","journal-title":"Theranostics"},{"issue":"18","key":"10.1016\/j.gendis.2025.101653_bib10","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.159578","article-title":"Chitinase 3 like 1 contributes to the development of pulmonary vascular remodeling in pulmonary hypertension","volume":"7","author":"Sun","year":"2022","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/j.gendis.2025.101653_bib11","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1016\/j.immuni.2023.11.002","article-title":"The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancer","volume":"56","author":"Taifour","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.gendis.2025.101653_bib12","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.2147\/JIR.S310831","article-title":"Nrf2 regulates CHI3L1 to suppress inflammation and improve post-traumatic osteoarthritis","volume":"14","author":"Song","year":"2021","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.gendis.2025.101653_bib13","article-title":"M2a macrophage-secreted CHI3L1 promotes extracellular matrix metabolic imbalances via activation of IL-13R\u03b12\/MAPK pathway in rat intervertebral disc degeneration","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101653_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3892\/ijo.2021.5293","article-title":"Chitinase 3-like 1 secreted from cancer-associated fibroblasts promotes tumor angiogenesis via interleukin-8 secretion in colorectal cancer","volume":"60","author":"Watanabe","year":"2022","journal-title":"Int J Oncol"},{"issue":"2","key":"10.1016\/j.gendis.2025.101653_bib15","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/1878-0261.13138","article-title":"A small molecule targeting CHI3L1 inhibits lung metastasis by blocking IL-13R\u03b12-mediated JNK-AP-1 signals","volume":"16","author":"Lee","year":"2022","journal-title":"Mol Oncol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101653_bib16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41392-020-00303-7","article-title":"Chitinase-3 like-protein-1 function and its role in diseases","volume":"5","author":"Zhao","year":"2020","journal-title":"Signal Transduct Targeted Ther"},{"issue":"4","key":"10.1016\/j.gendis.2025.101653_bib17","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.celrep.2013.07.032","article-title":"Chitinase 3-like 1 regulates cellular and tissue responses via IL-13 receptor \u03b12","volume":"4","author":"He","year":"2013","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/j.gendis.2025.101653_bib18","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.bbrc.2009.08.024","article-title":"YKL-40 secreted from adipose tissue inhibits degradation of type I collagen","volume":"388","author":"Iwata","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1016\/j.gendis.2025.101653_bib19","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.imbio.2011.11.003","article-title":"The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failure","volume":"217","author":"Harutyunyan","year":"2012","journal-title":"Immunobiology"},{"issue":"3","key":"10.1016\/j.gendis.2025.101653_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1349-7006.2005.00026.x","article-title":"Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells","volume":"96","author":"Junker","year":"2005","journal-title":"Cancer Sci"},{"issue":"4","key":"10.1016\/j.gendis.2025.101653_bib21","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/all.13661","article-title":"Chitinase 3-like 1 protein plays a critical role in respiratory syncytial virus-induced airway inflammation","volume":"74","author":"Kim","year":"2019","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.gendis.2025.101653_bib22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1165\/rcmb.2021-0504OC","article-title":"CRTH2 mediates profibrotic macrophage differentiation and promotes lung fibrosis","volume":"67","author":"Cao","year":"2022","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"10.1016\/j.gendis.2025.101653_bib23","doi-asserted-by":"crossref","first-page":"749","DOI":"10.7150\/thno.20183","article-title":"Atherosclerosis is exacerbated by chitinase-3-like-1 in amyloid precursor protein transgenic mice","volume":"8","author":"Jung","year":"2018","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.gendis.2025.101653_bib24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/alz.12612","article-title":"Potential role of chitinase-3-like protein 1 (CHI3L1\/YKL-40) in neurodegeneration and Alzheimer's disease","volume":"19","author":"Connolly","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.gendis.2025.101653_bib25","doi-asserted-by":"crossref","first-page":"340","DOI":"10.7150\/thno.65522","article-title":"Targeting protumor factor chitinase-3-like-1 secreted by Rab37 vesicles for cancer immunotherapy","volume":"12","author":"Yang","year":"2022","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.gendis.2025.101653_bib26","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/ijc.25466","article-title":"CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells","volume":"128","author":"Ku","year":"2011","journal-title":"Int J Cancer"},{"issue":"24","key":"10.1016\/j.gendis.2025.101653_bib27","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1111\/jcmm.18012","article-title":"Functional variants of the chitinase 3-like 1 gene are associated with clinicopathologic outcomes and progression of prostate cancer","volume":"27","author":"Wen","year":"2023","journal-title":"J Cell Mol Med"},{"issue":"3","key":"10.1016\/j.gendis.2025.101653_bib28","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.pathol.2017.09.015","article-title":"Chitinase 3 like 1 (CHI3L1) promotes vasculogenic mimicry formation in cervical cancer","volume":"50","author":"Ngernyuang","year":"2018","journal-title":"Pathology"},{"issue":"10","key":"10.1016\/j.gendis.2025.101653_bib29","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1089\/omi.2014.0090","article-title":"Metadata checklist: identification of CHI3L1 and MASP2 as a biomarker pair for liver cancer through integrative secretome and transcriptome analysis","volume":"18","author":"Ding","year":"2014","journal-title":"OMICS"},{"issue":"4","key":"10.1016\/j.gendis.2025.101653_bib30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1089\/omi.2019.0035","article-title":"Novel serum biomarkers for noninvasive diagnosis and screening of nonalcoholic fatty liver disease-related hepatic fibrosis","volume":"23","author":"Lin","year":"2019","journal-title":"OMICS"},{"issue":"168","key":"10.1016\/j.gendis.2025.101653_bib31","first-page":"41","article-title":"Serum CHI3L1 as a biomarker for non-invasive diagnosis of liver fibrosis","volume":"33","author":"Bao","year":"2022","journal-title":"Discov Med"},{"issue":"4","key":"10.1016\/j.gendis.2025.101653_bib32","doi-asserted-by":"crossref","first-page":"537","DOI":"10.5009\/gnl.2010.4.4.537","article-title":"Utility of serum YKL-40 as a tumor-specific marker of hepatobiliary malignancies","volume":"4","author":"Yang","year":"2010","journal-title":"Gut Liver"},{"key":"10.1016\/j.gendis.2025.101653_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.854570","article-title":"Increased levels of CHI3L1 and HA are associated with higher occurrence of liver damage in patients with obstructive sleep apnea","volume":"9","author":"Cai","year":"2022","journal-title":"Front Med"},{"issue":"17","key":"10.1016\/j.gendis.2025.101653_bib34","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2019633118","article-title":"Chitinase 3-like 1 is a profibrogenic factor overexpressed in the aging liver and in patients with liver cirrhosis","volume":"118","author":"Nishimura","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.gendis.2025.101653_bib35","first-page":"721","article-title":"Guidelines for the diagnosis and management of hepatic encephalopathy in cirrhosis","volume":"26","year":"2018","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"1","key":"10.1016\/j.gendis.2025.101653_bib36","first-page":"52","article-title":"Study of clinical outcome and prognosis in pediatric core binding factor-acute myeloid leukemia","volume":"40","author":"Wu","year":"2019","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"10407","key":"10.1016\/j.gendis.2025.101653_bib37","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(23)01320-X","article-title":"Hepatitis C","volume":"402","author":"Martinello","year":"2023","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.gendis.2025.101653_bib38","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S2468-1253(22)00386-7","article-title":"Global reporting of progress towards elimination of hepatitis B and hepatitis C","volume":"8","author":"Cui","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.gendis.2025.101653_bib39","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/gast.1997.v112.pm9024300","article-title":"Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients","volume":"112","author":"Fattovich","year":"1997","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.gendis.2025.101653_bib40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMra2211764","article-title":"New approaches to chronic hepatitis B","volume":"388","author":"Dusheiko","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.gendis.2025.101653_bib41","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"AASLD guidelines for treatment of chronic hepatitis B","volume":"63","author":"Terrault","year":"2016","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.gendis.2025.101653_bib42","first-page":"1021","article-title":"Medical practices and expectations of general practitioners in relation to hepatitis C virus infection in the Auvergne region","volume":"27","author":"Bonny","year":"2003","journal-title":"Gastroenterol Clin Biol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101653_bib43","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","article-title":"Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH clinical practice guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis","volume":"63","year":"2015","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.gendis.2025.101653_bib44","first-page":"182","article-title":"Liver disease committee of Chinese Research Hospital Association. Consensus on clinical application of transient elastography detecting liver fibrosis: a 2018 update","volume":"27","year":"2019","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"1","key":"10.1016\/j.gendis.2025.101653_bib45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.dld.2011.08.004","article-title":"Improving transient elastography performance for detecting hepatitis B cirrhosis","volume":"44","author":"Chen","year":"2012","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.gendis.2025.101653_bib46","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/6688819","article-title":"Analytical and clinical evaluation of a chemiluminescent immunoassay to detect serum chitinase-3-like protein 1 in HBV-Related liver diseases","volume":"2024","author":"Liao","year":"2024","journal-title":"Int J Anal Chem"},{"issue":"4","key":"10.1016\/j.gendis.2025.101653_bib47","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.4103\/jfmpc.jfmpc_1922_20","article-title":"Evaluation of chitinase 3-like 1 (CHI3L1) as a noninvasive biomarker of hepatic fibrosis in patients with Hepatitis B virus-related compensated chronic liver disease","volume":"10","author":"Das","year":"2021","journal-title":"J Fam Med Prim Care"},{"issue":"5","key":"10.1016\/j.gendis.2025.101653_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23200","article-title":"The clinical significance of serum chitinase 3-like 1 in hepatitis B-related chronic liver diseases","volume":"34","author":"Jiang","year":"2020","journal-title":"J Clin Lab Anal"},{"issue":"6","key":"10.1016\/j.gendis.2025.101653_bib49","first-page":"4090","article-title":"Serum CHI3L1 as a diagnostic marker and risk factor for liver fibrosis in HBeAg-negative chronic hepatitis B","volume":"14","author":"Li","year":"2022","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.gendis.2025.101653_bib50","first-page":"120","article-title":"Serum level of YKL-40 does not predict advanced liver fibrosis in children with chronic hepatitis B","volume":"52","author":"Lebensztejn","year":"2007","journal-title":"Adv Med Sci"},{"issue":"5","key":"10.1016\/j.gendis.2025.101653_bib51","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.21037\/apm-21-957","article-title":"A noninvasive diagnostic model for significant liver fibrosis in patients with chronic hepatitis B based on CHI3L1 and routine clinical indicators","volume":"10","author":"Huang","year":"2021","journal-title":"Ann Palliat Med"},{"issue":"3","key":"10.1016\/j.gendis.2025.101653_bib52","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s15010-018-1136-2","article-title":"China HepB-Related fibrosis assessment research group. Serum YKL-40 as a biomarker for liver fibrosis in chronic hepatitis B patients with normal and mildly elevated ALT","volume":"46","author":"Yan","year":"2018","journal-title":"Infection"},{"issue":"2","key":"10.1016\/j.gendis.2025.101653_bib53","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2008.09.016","article-title":"A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection","volume":"50","author":"Berres","year":"2009","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.gendis.2025.101653_bib54","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3109\/00365521003637203","article-title":"YKL-40 and hyaluronic acid (HA) as noninvasive markers of liver fibrosis in kidney transplant patients with HCV chronic infection","volume":"45","author":"Schiavon","year":"2010","journal-title":"Scand J Gastroenterol"},{"issue":"11","key":"10.1016\/j.gendis.2025.101653_bib55","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3109\/00365521.2011.613949","article-title":"YKL-40 and transient elastography, a powerful team to assess hepatic fibrosis","volume":"46","author":"Rath","year":"2011","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"10.1016\/j.gendis.2025.101653_bib56","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/MEG.0000000000001291","article-title":"Comparison of chitinase-3-like protein 1, aspartate aminotransferase-to-platelet ratio index, and fibrosis-4 index with shear-wave elastography","volume":"31","author":"Mushtaq","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.gendis.2025.101653_bib57","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1572-0241.2007.01761.x","article-title":"Diagnostic accuracy of serum hyaluronic acid, FIBROSpect II, and YKL-40 for discriminating fibrosis stages in chronic hepatitis C","volume":"103","author":"Mehta","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.gendis.2025.101653_bib58","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1365-2893.2008.00992.x","article-title":"Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection","volume":"15","author":"Schiavon","year":"2008","journal-title":"J Viral Hepat"},{"issue":"3","key":"10.1016\/j.gendis.2025.101653_bib59","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/hep.22099","article-title":"Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C","volume":"47","author":"Fontana","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.gendis.2025.101653_bib60","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.2147\/IJGM.S364602","article-title":"The value of serum CHI3L1 for the diagnosis of chronic liver diseases","volume":"15","author":"Qiu","year":"2022","journal-title":"Int J Gen Med"},{"issue":"4","key":"10.1016\/j.gendis.2025.101653_bib61","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.hbpd.2020.05.009","article-title":"Serum chitinase-3-like protein 1 is a biomarker of liver fibrosis in patients with chronic hepatitis B in China","volume":"19","author":"Jin","year":"2020","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"1","key":"10.1016\/j.gendis.2025.101653_bib62","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1440-1746.2012.07270.x","article-title":"YKL-40-gene polymorphism affects acute cellular rejection and fibrosis progression after transplantation for hepatitis C virus-induced liver disease","volume":"28","author":"Eurich","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.gendis.2025.101653_bib63","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cgh.2008.10.034","article-title":"Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosis","volume":"7","author":"Fontana","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.gendis.2025.101653_bib64","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3748\/wjg.v11.i4.476","article-title":"Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease","volume":"11","author":"Saitou","year":"2005","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.gendis.2025.101653_bib65","doi-asserted-by":"crossref","first-page":"E283","DOI":"10.1111\/hepr.12982","article-title":"Changes in serum chitinase 3-like 1 levels correlate with changes in liver fibrosis measured by two established quantitative methods in chronic hepatitis B patients following antiviral therapy","volume":"48","author":"Wang","year":"2018","journal-title":"Hepatol Res"},{"issue":"4","key":"10.1016\/j.gendis.2025.101653_bib66","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jhep.2006.12.010","article-title":"Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C","volume":"46","author":"Esmat","year":"2007","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.gendis.2025.101653_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.arcmed.2024.103043","article-title":"Global prevalence of nonalcoholic fatty liver disease: an updated review meta-analysis comprising a population of 78 million from 38 countries","volume":"55","author":"Amini-Salehi","year":"2024","journal-title":"Arch Med Res"},{"issue":"6","key":"10.1016\/j.gendis.2025.101653_bib68","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jhep.2021.08.012","article-title":"Epidemiology and risk-stratification of NAFLD-associated HCC","volume":"75","author":"Ioannou","year":"2021","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.gendis.2025.101653_bib69","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.gendis.2025.101653_bib70","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jhep.2017.11.013","article-title":"Non-invasive assessment of non-alcoholic fatty liver disease: clinical prediction rules and blood-based biomarkers","volume":"68","author":"Vilar-Gomez","year":"2018","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.gendis.2025.101653_bib71","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/hep.23050","article-title":"Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study","volume":"50","author":"Feldstein","year":"2009","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.gendis.2025.101653_bib72","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.cgh.2008.07.016","article-title":"Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients","volume":"6","author":"Diab","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.gendis.2025.101653_bib73","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/hep.24734","article-title":"Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis","volume":"55","author":"Joka","year":"2012","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.gendis.2025.101653_bib74","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/hep.21223","article-title":"In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease","volume":"44","author":"Wieckowska","year":"2006","journal-title":"Hepatology"},{"issue":"11\u201312","key":"10.1016\/j.gendis.2025.101653_bib75","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1365-2036.2010.04480.x","article-title":"A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients","volume":"32","author":"Anty","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.gendis.2025.101653_bib76","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2001.25540","article-title":"Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese","volume":"121","author":"Dixon","year":"2001","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.gendis.2025.101653_bib77","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1478-3231.2005.01209.x","article-title":"Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease","volume":"26","author":"Palekar","year":"2006","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.gendis.2025.101653_bib78","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1572-0241.2006.01041.x","article-title":"Nonalcoholic fatty liver disease in severely obese subjects","volume":"102","author":"Gholam","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gendis.2025.101653_bib79","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-230X-6-34","article-title":"Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease","volume":"6","author":"Poynard","year":"2006","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"10.1016\/j.gendis.2025.101653_bib80","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/hep.22241","article-title":"A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients","volume":"47","author":"Campos","year":"2008","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.gendis.2025.101653_bib81","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s11695-010-0118-y","article-title":"A noninvasive clinical scoring model predicts risk of nonalcoholic steatohepatitis in morbidly obese patients","volume":"20","author":"Ulitsky","year":"2010","journal-title":"Obes Surg"},{"issue":"6","key":"10.1016\/j.gendis.2025.101653_bib82","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/MEG.0b013e3283464111","article-title":"Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity","volume":"23","author":"Lassailly","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.gendis.2025.101653_bib83","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jhep.2013.12.009","article-title":"A population-based study on the prevalence of NASH using scores validated against liver histology","volume":"60","author":"Hyysalo","year":"2014","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.gendis.2025.101653_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142661","article-title":"Performance of serum microRNA-122, -192, and -21 as biomarkers in patients with non-alcoholic steatohepatitis","volume":"10","author":"Becker","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.gendis.2025.101653_bib85","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/gutjnl-2014-306996","article-title":"Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis","volume":"64","author":"Pirola","year":"2015","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.gendis.2025.101653_bib86","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S2468-1253(20)30252-1","article-title":"A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study","volume":"5","author":"Harrison","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.gendis.2025.101653_bib87","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jhep.2023.04.031","article-title":"NIS2+\u2122, an optimisation of the blood-based biomarker NIS4\u00ae technology for the detection of at-risk NASH: a prospective derivation and validation study","volume":"79","author":"Harrison","year":"2023","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.gendis.2025.101653_bib88","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1007\/s11845-024-03671-z","article-title":"Association between chitinase-3-like protein 1 and metabolic-associated fatty liver disease in patients with type 2 diabetes mellitus","volume":"193","author":"Zhang","year":"2024","journal-title":"Ir J Med Sci"},{"issue":"4","key":"10.1016\/j.gendis.2025.101653_bib89","doi-asserted-by":"crossref","first-page":"563","DOI":"10.18388\/abp.2011_2225","article-title":"Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease","volume":"58","author":"Lebensztejn","year":"2011","journal-title":"Acta Biochim Pol"},{"issue":"4","key":"10.1016\/j.gendis.2025.101653_bib90","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1440-1746.2008.05731.x","article-title":"The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease","volume":"24","author":"Malik","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.gendis.2025.101653_bib91","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/hepr.13464","article-title":"Serum soluble sialic acid-binding immunoglobulin-like lectin-7 concentration as an indicator of liver macrophage activation and advanced fibrosis in patients with non-alcoholic fatty liver disease","volume":"50","author":"Sakamoto","year":"2020","journal-title":"Hepatol Res"},{"issue":"8","key":"10.1016\/j.gendis.2025.101653_bib92","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1177\/2050640619868352","article-title":"Individualized risk prediction of significant fibrosis in non-alcoholic fatty liver disease using a novel nomogram","volume":"7","author":"Zhou","year":"2019","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.gendis.2025.101653_bib93","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.2147\/DMSO.S417754","article-title":"Association of non-invasive markers with significant fibrosis in patients with nonalcoholic fatty liver disease: a cross-sectional study","volume":"16","author":"Zhang","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.gendis.2025.101653_bib94","doi-asserted-by":"crossref","DOI":"10.1038\/srep35282","article-title":"Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"6","author":"Kumagai","year":"2016","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.gendis.2025.101653_bib95","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3109\/00365529709025104","article-title":"Plasma YKL-40: a new potential marker of fibrosis in patients with alcoholic cirrhosis?","volume":"32","author":"Johansen","year":"1997","journal-title":"Scand J Gastroenterol"},{"issue":"9","key":"10.1016\/j.gendis.2025.101653_bib96","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/00042737-200012090-00004","article-title":"Chondrex (YKL-40), a potential new serum fibrosis marker in patients with alcoholic liver disease","volume":"12","author":"Tran","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.gendis.2025.101653_bib97","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0168-8278(03)00184-3","article-title":"Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease","volume":"39","author":"N\u00f8jgaard","year":"2003","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.gendis.2025.101653_bib98","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1499-3872(11)60103-3","article-title":"YKL-40 expression in human hepatocellular carcinoma: a potential biomarker?","volume":"10","author":"Xiao","year":"2011","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"2","key":"10.1016\/j.gendis.2025.101653_bib99","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24234","article-title":"Diagnostic and prognostic value of serum chitinase 3-like protein 1 in hepatocellular carcinoma","volume":"36","author":"Wang","year":"2022","journal-title":"J Clin Lab Anal"},{"issue":"6","key":"10.1016\/j.gendis.2025.101653_bib100","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s00432-013-1415-3","article-title":"The expression of chitinase 3-like 1: a novel prognostic predictor for hepatocellular carcinoma","volume":"139","author":"Pan","year":"2013","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"10.1016\/j.gendis.2025.101653_bib101","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1245\/s10434-011-2026-3","article-title":"Elevated serum YKL-40 level predicts poor prognosis in hepatocellular carcinoma after surgery","volume":"19","author":"Zhu","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.gendis.2025.101653_bib102","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044648","article-title":"Serum YKL-40 independently predicts outcome after transcatheter arterial chemoembolization of hepatocellular carcinoma","volume":"7","author":"Zhu","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.gendis.2025.101653_bib103","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/iub.2444","article-title":"Chitinase 3-like-1, Tolloid-like protein 1, and intergenic gene polymorphisms are predictors for hepatocellular carcinoma development after hepatitis C virus eradication by direct-acting antivirals","volume":"73","author":"Mangoud","year":"2021","journal-title":"IUBMB Life"},{"issue":"7","key":"10.1016\/j.gendis.2025.101653_bib104","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/09513590.2018.1563889","article-title":"Inflammatory marker YKL-40 levels in intrahepatic cholestasis of pregnancy","volume":"35","author":"Temel Y\u00fcksel","year":"2019","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"10.1016\/j.gendis.2025.101653_bib105","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.aohep.2019.06.009","article-title":"Effect of laparoscopic splenectomy on portal vein thrombosis and serum YKL-40 in patients with cirrhotic portal hypertension","volume":"18","author":"Qi","year":"2019","journal-title":"Ann Hepatol"},{"issue":"3","key":"10.1016\/j.gendis.2025.101653_bib106","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1590\/S0100-879X2012007500010","article-title":"Increased immunohistochemical expression of YKL-40 in the spleen of patients with portal hypertension","volume":"45","author":"Wang","year":"2012","journal-title":"Braz J Med Biol Res"},{"issue":"1","key":"10.1016\/j.gendis.2025.101653_bib107","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"10.1016\/j.gendis.2025.101653_bib108","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/sj.onc.1209141","article-title":"Clusterin plays an important role in hepatocellular carcinoma metastasis","volume":"25","author":"Lau","year":"2006","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.gendis.2025.101653_bib109","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33239-8","article-title":"CHI3L1 promotes tumor progression by activating TGF-\u03b2 signaling pathway in hepatocellular carcinoma","volume":"8","author":"Qiu","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.gendis.2025.101653_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102538","article-title":"Multi-omics profiling reveals chitinase-3-like protein 1 as a key mediator in the crosstalk between sarcopenia and liver cancer","volume":"58","author":"Lu","year":"2022","journal-title":"Redox Biol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101653_bib111","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13045-017-0408-0","article-title":"Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein","volume":"10","author":"Chen","year":"2017","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101653_bib112","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1186\/s12967-023-04532-6","article-title":"Cancer stem cell-derived CHI3L1 activates the MAF\/CTLA4 signaling pathway to promote immune escape in triple-negative breast cancer","volume":"21","author":"Ji","year":"2023","journal-title":"J Transl Med"},{"issue":"21","key":"10.1016\/j.gendis.2025.101653_bib113","doi-asserted-by":"crossref","DOI":"10.1172\/JCI137750","article-title":"CHI3L1 regulates PD-L1 and anti-CHI3L1-PD-1 antibody elicits synergistic antitumor responses","volume":"131","author":"Ma","year":"2021","journal-title":"J Clin Investig"},{"issue":"1","key":"10.1016\/j.gendis.2025.101653_bib114","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2388801","article-title":"Porphyromonas gingivalis fuels colorectal cancer through CHI3L1-mediated iNKT cell-driven immune evasion","volume":"16","author":"D\u00edaz-Basabe","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.gendis.2025.101653_bib115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1056397","article-title":"CHI3L1 enhances melanoma lung metastasis via regulation of T cell co-stimulators and CTLA-4\/B7 axis","volume":"13","author":"Ma","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101653_bib116","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41467-017-02731-6","article-title":"Regulation of chitinase-3-like-1 in T cell elicits Th1 and cytotoxic responses to inhibit lung metastasis","volume":"9","author":"Kim","year":"2018","journal-title":"Nat Commun"},{"issue":"22","key":"10.1016\/j.gendis.2025.101653_bib117","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.21037\/atm-21-4537","article-title":"Reciprocal induction of hepatitis C virus replication and stimulation of hepatic profibrogenic cytokine release and cellular viability by YKL-40","volume":"9","author":"Cheng","year":"2021","journal-title":"Ann Transl Med"},{"issue":"11","key":"10.1016\/j.gendis.2025.101653_bib118","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/hepr.13396","article-title":"Chitinase 3-like 1 deficiency ameliorates liver fibrosis by promoting hepatic macrophage apoptosis","volume":"49","author":"Higashiyama","year":"2019","journal-title":"Hepatol Res"},{"issue":"26","key":"10.1016\/j.gendis.2025.101653_bib119","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1056\/NEJMra1208937","article-title":"Acute liver failure","volume":"369","author":"Bernal","year":"2013","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.gendis.2025.101653_bib120","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1159\/000374090","article-title":"Acetaminophen: dose-dependent drug hepatotoxicity and acute liver failure in patients","volume":"33","author":"Jaeschke","year":"2015","journal-title":"Dig Dis"},{"key":"10.1016\/j.gendis.2025.101653_bib121","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/bs.apha.2018.12.004","article-title":"Evaluation and treatment of acetaminophen toxicity","volume":"85","author":"Fisher","year":"2019","journal-title":"Adv Pharmacol"},{"issue":"6","key":"10.1016\/j.gendis.2025.101653_bib122","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1002\/hep.29733","article-title":"Chitinase 3-like-1 promotes intrahepatic activation of coagulation through induction of tissue factor in mice","volume":"67","author":"Shan","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.gendis.2025.101653_bib123","article-title":"YKL-40 promotes chemokine expression following drug-induced liver injury via TF-PAR1 pathway in mice","volume":"14","author":"Zhan","year":"2023","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.gendis.2025.101653_bib124","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-2007-991512","article-title":"Immune-mediated liver injury","volume":"27","author":"Eksteen","year":"2007","journal-title":"Semin Liver Dis"},{"issue":"3","key":"10.1016\/j.gendis.2025.101653_bib125","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41419-021-03524-y","article-title":"Mesenchymal stem cells alleviate experimental immune-mediated liver injury via chitinase 3-like protein 1-mediated T cell suppression","volume":"12","author":"Liu","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.gendis.2025.101653_bib126","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.68571","article-title":"Chitinase 3-like-1 contributes to acetaminophen-induced liver injury by promoting hepatic platelet recruitment","volume":"10","author":"Shan","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.gendis.2025.101653_bib127","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.metabol.2019.03.010","article-title":"Chitinase-3-like-1 deficiency attenuates ethanol-induced liver injury by inhibition of sterol regulatory element binding protein 1-dependent triglyceride synthesis","volume":"95","author":"Lee","year":"2019","journal-title":"Metabolism"},{"issue":"14","key":"10.1016\/j.gendis.2025.101653_bib128","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.7150\/thno.83163","article-title":"5-aminolevulinate and CHIL3\/CHI3L1 treatment amid ischemia aids liver metabolism and reduces ischemia-reperfusion injury","volume":"13","author":"Jin","year":"2023","journal-title":"Theranostics"},{"issue":"2\u20133","key":"10.1016\/j.gendis.2025.101653_bib129","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.trim.2013.12.003","article-title":"Protective role of bortezomib in steatotic liver ischemia\/reperfusion injury through abrogation of MMP activation and YKL-40 expression","volume":"30","author":"Tiriveedhi","year":"2014","journal-title":"Transpl Immunol"},{"issue":"2","key":"10.1016\/j.gendis.2025.101653_bib130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148815","article-title":"The impact of ischemia\/reperfusion injury on liver allografts from deceased after cardiac death versus deceased after brain death donors","volume":"11","author":"Xu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.gendis.2025.101653_bib131","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bbrc.2021.03.048","article-title":"Effects of chitinase-3-like protein 1 on brain death-induced hepatocyte apoptosis via PAR2-JNK-caspase-3","volume":"552","author":"Li","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.gendis.2025.101653_bib132","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.molimm.2023.02.012","article-title":"Chitinase 3 like 1 deficiency ameliorates lipopolysaccharide-induced acute liver injury by inhibition of M2 macrophage polarization","volume":"156","author":"Kim","year":"2023","journal-title":"Mol Immunol"},{"issue":"3","key":"10.1016\/j.gendis.2025.101653_bib133","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jcmgh.2023.12.002","article-title":"BRP39 regulates neutrophil recruitment in NLRP3 inflammasome-induced liver inflammation","volume":"17","author":"Kui","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"33","key":"10.1016\/j.gendis.2025.101653_bib134","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.3748\/wjg.v17.i33.3830","article-title":"YKL-40 expression in CD14+ liver cells in acute and chronic injury","volume":"17","author":"Pizano-Mart\u00ednez","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gendis.2025.101653_bib135","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.intimp.2017.03.010","article-title":"Chitinase 3-like-1 deficient donor splenocytes accentuated the pathogenesis of acute graft-versus-host diseases through regulating T cell expansion and type I inflammation","volume":"46","author":"Li","year":"2017","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"10.1016\/j.gendis.2025.101653_bib136","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3390\/cells10020201","article-title":"Role of chitinase 3-like 1 protein in the pathogenesis of hepatic insulin resistance in nonalcoholic fatty liver disease","volume":"10","author":"Zhang","year":"2021","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.gendis.2025.101653_bib137","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00109-023-02325-4","article-title":"Myeloid-specific deletion of chitinase-3-like 1 protein ameliorates murine diet-induced steatohepatitis progression","volume":"101","author":"Kim","year":"2023","journal-title":"J Mol Med (Berl)"}],"container-title":["Genes & Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304225001424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304225001424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:18:11Z","timestamp":1762543091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304225001424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":137,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2352304225001424"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2025.101653","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of chitinase-3-like protein 1 in liver diseases: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2025.101653","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd\u00e9","name":"copyright","label":"Copyright"}],"article-number":"101653"}}